Europe’s science is world-class. The capital pipeline isn’t. “Germany has excellent basic research — but too often fails to secure the right capital to turn ideas into real R&D, clinical development, and products.” Patrick van der Loo (Country President Pfizer Germany) at #biocap26 on the critical gap in Europe’s life-science ecosystem. 👇
bio:cap
Veranstaltungsdienste
Berlin, BE 3.581 Follower:innen
Life Science & AI Investival 🚀 June 29-30, 2027
Info
International Life Science & AI Investival 🌍 Innovation. Capital. Politics — coming together in a whole new festival format. From June 9–11, 2026, Germany’s capital will become a central hub for life sciences in Europe and across the globe. From biotech and TechBio to diagnostics and artificial intelligence – this is where bold scientific and industrial innovation meets capital and politics. bio:cap is hosted by Messe Berlin in cooperation with leading institutions in science and medicine. Held under the patronage of Charité – Universitätsmedizin Berlin and the Berlin Institute of Health (BIH), and supported by the Hasso Plattner Institute (HPI), the event breaks traditional boundaries and creates a new platform for interdisciplinary exchange. The goal: to connect investors, start-ups, and top life science innovators with the global pharma industry, leading AI pioneers, and political stakeholders. Together, they will discover groundbreaking ideas, invest in high-potential ventures, and help shape the societal and political framework for the life science and innovation landscape of tomorrow. Because while Europe excels in cutting-edge research, it still has untapped potential when it comes to translating discoveries into market success and scalable growth.
- Website
-
http://biocap-europe.com
Externer Link zu bio:cap
- Branche
- Veranstaltungsdienste
- Größe
- 11–50 Beschäftigte
- Hauptsitz
- Berlin, BE
- Gegründet
- 2025
- Spezialgebiete
- Biotech und AI
Updates
-
This is huge! 🔥 With Fresenius Group Ventures, another major European healthcare player is stepping up to back the next wave of innovators at the intersection of biotech and healthcare – exactly the kind of capital that Europe needs more of. #biocap27 #LifeSciences #Investival #FutureFresenius
Today marks an exciting milestone for Fresenius Group: We are launching Fresenius Ventures, our corporate venture capital fund. Over the next five years, we intend to invest more than €200 million in promising healthcare innovators. In doing so, we will gain early access to breakthrough technologies, fresh ideas, and entrepreneurial talent that can help improve care for patients around the world. Healthcare is entering a new era. Advances in AI, smart data, and biological research are fundamentally transforming how we prevent, diagnose, and treat diseases. With Fresenius Ventures, we want to help bring innovations to patients faster. I am delighted that Thomas Michael Thestrup will lead Fresenius Ventures. His extensive experience in venture investing and healthcare makes him the ideal person to build this new platform and partner with ambitious entrepreneurs. Welcome on board, Thomas and the team! Few companies can match the combination of medical expertise, clinical access, and global reach that Fresenius brings. Every year, we care for 27 million patients in our clinics and our products reach around 450 million people. This gives us a strong platform to scale new solutions and make them available to patients. The future of healthcare will be shaped by strong innovation ecosystems. Fresenius Ventures is an important addition to our ecosystem, alongside initiatives such as our strategic partnership with SAP. With Fresenius Ventures, we are taking another important step on our #FutureFresenius journey. It will give us earlier access to emerging opportunities and enable us to act more quickly when they arise. I look forward to seeing the ideas and investments backed by Fresenius Ventures translate into better patient outcomes and broader access to healthcare. #FutureFresenius #Fresenius #CommittedToLife
-
RECAP! 🚀 #biocap26 was more than just another conference: Science × AI × Capital × Policy converged to shape Europe’s healthcare future. And we're only getting started! An idea became a community: 3,000+ participants from 35+ countries, 530+ start-ups, 115+ exhibitors, 150+ investors, and 750+ curated 1:1 meetings — all united by the ambition to translate breakthrough science into scalable healthcare solutions! #SaveTheDate for #biocap27 29–30 June 2027 | Berlin
-
bio:cap hat dies direkt geteilt
Can hardly wait for bio:cap 2027 – save the date now! Our first “bio:cap Europe” was a fantastic event – over 3,000 attendees from more than 30 countries, hundreds of start-ups, investors and global brands. We’re already brimming with ideas for next year and have plenty more to come. If you want to be among the first to join the community, just let us know: www.biocap-europe.com btw: Here are a few highlights from bc 26 to whet your appetite. See you in Berlin on 29 & 30 of June 2027!
-
Two weeks since bio:cap turned up the volume! ✨ Here’s what the #biocap26 #Investival vibe really feels like: creative energy at Teufelsberg Berlin’s iconic graffiti workshop, inspiration at Fotografiska, and pure celebration at the legendary AVUS Tribüne night. Science meets street art. Ideas flow freely. Connections happen in the most unforgettable settings. This is what turning Europe’s science into scale looks like in the moments that matter! 🌇🤘
-
Prof. Dr. Ariel Dora Stern at #biocap26 urges us to look to pharma R&D for the real revolution: using AI to completely rethink how we discover, develop, and deliver breakthroughs. The future isn’t incremental. It’s transformative. 🤖
-
bio:cap hat dies direkt geteilt
Having speakers such as NASA astronaut Dr. Kate Rubins, European Commissioner Olivér Várhelyi, Taiwan’s former Digital Minister Audrey Tang, German Federal Minister Dorothee Bär, and Nobel Prize-winning scientist Prof. Dr. Stefan Hell on stage makes the conference shine. But the people who make it happen behind the scenes are even more important.The ones who turn ideas into reality. The ones who solve problems before they become visible. The ones who coordinate countless moving parts and remain committed to excellence long before the spotlight turns on and long after it fades. So today, I want to say a very special thank you. To the fantastic team making the stage program at bio:cap possible — Luisa Gricksch Kira Wiesner Alina Sachs Felix Josephi Carola Bergmann Frank Reichert Dewi Petzschner Rudi Schaarschmidt Sebastian Treu Timur Sarkisov Alla Bokun Nicole Rebhuhn Maria Arlt — thank you for all your support and incredible dedication. To Helena Smolak Nicole Bastian Astrid Doerner and Daniel Rettig — thank you for your outstanding moderation and for your ideas and expertise in helping me build the program from the very beginning and bring it to life on stage. And, of course, to my two favorite power ladies: Lara Formichella and Marie-Kristin Kalz. Working with you over the past months has been an absolute pleasure. Lara, bio:cap would simply be nothing without you. Marie, you rock! Great speakers can inspire an audience. Great teams make inspiration possible. bio:cap became something truly special because of all of you. #TeamworkMakesTheDreamWork Handelsblatt Live Messe Berlin bio:cap
-
-
-
-
-
+5
-
-
From strategy sessions to spray cans: #biocap26 at Teufelsberg Berlin! Our participants turned Berlin’s iconic Cold War listening station into a living canvas — painting a massive double helix against a backdrop of raw history in the Grunewald forest. Unpolished, inspiring, and refreshingly real. Exactly how great ideas (and connections) emerge when you step outside the usual format. bio:cap #Investival at its best! 🙌
-